RAVENSBURG, Germany--(BUSINESS WIRE)--Vetter, a leading contract development and manufacturing organization (CDMO) that specializes in aseptic filling, has announced that the French Ministry for Higher Education and Research recently has renewed the recognition of Vetter as an approved research and development service provider. This re-approval continues to allow companies, subject to the French General Tax Code, to take advantage of the research and development tax credit available in France when outsouring parenteral drug product development activities to Vetter. The renewed approval is granted for the years 2015-2019.
Help employers find you! Check out all the jobs and post your resume.
